These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3481322)

  • 1. Application of ofloxacin in gynaecology.
    Petersen EE; de Isele TS; Pelz K; Weiss N
    Drugs; 1987; 34 Suppl 1():183-6. PubMed ID: 3481322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Personal experience with ofloxacin in patients with resistant urinary tract infections].
    Horácková M; Osten J; Potuzník V
    Vnitr Lek; 1988 Jun; 34(6):545-9. PubMed ID: 3166276
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical study of T-3761 in obstetrics and gynaecology.
    Matsuda S
    Drugs; 1995; 49 Suppl 2():393-4. PubMed ID: 8549374
    [No Abstract]   [Full Text] [Related]  

  • 6. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW
    Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Chlamydia trachomatis as a cause of lower urogenital tract infection.
    Johannisson G
    Acta Derm Venereol Suppl (Stockh); 1981; 93():1-55. PubMed ID: 6945025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of ofloxacin on mice challenged by ofloxacin-resistant Mycobacterium bovis strains].
    Tsukamura M
    Kekkaku; 1987 Apr; 62(4):235-8. PubMed ID: 3306084
    [No Abstract]   [Full Text] [Related]  

  • 9. Ofloxacin versus doxycycline in gynecological infections.
    Schneider A; Weissenbacher ER; Gutschow K; Wachter I
    Acta Eur Fertil; 1987; 18(2):121-2. PubMed ID: 3477052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ofloxacin in the treatment of gynecologic and obstetrical infections].
    Grcić R; Ivanović L; Stavrić V; Kadija D; Miković Z
    Med Pregl; 1987; 40(3-4):129-32. PubMed ID: 3478554
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy.
    Cheng AF; Li MK; Ling TK; French GL
    J Antimicrob Chemother; 1987 Aug; 20(2):283-5. PubMed ID: 3478330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of complicated urinary tract infections using ofloxacin--a 2d generation antibacterial quinolone].
    Prát V; Horcicková M; Matousovic K; Hatala M; Janda P; Milotová Z
    Cas Lek Cesk; 1988 May; 127(19):586-8. PubMed ID: 3165054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections.
    Vellucci A; Bernardini G; Battaglia AM; Battaglia P
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):279-81. PubMed ID: 3496284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory and clinical study of T-3761, a new fluoroquinolone, in urinary tract infection.
    Suzuki K; Horiba Y; Ishikawa K; Katoh S; Naide Y; Yanaoka L; Andoh S
    Drugs; 1995; 49 Suppl 2():379-81. PubMed ID: 8549368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?].
    Viñuela L; de Frutos-Serna M; Asensio ML; Muñoz-Bellido JL; García-Sánchez JE
    Rev Esp Quimioter; 2013 Jun; 26(2):159-61. PubMed ID: 23817654
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological and clinical experiences with ofloxacin in urinary tract infections.
    Fröhlich G; Stratmeyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):525-6. PubMed ID: 3509489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of ofloxacin against complicated urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Niederriter K
    J Infect Dis; 1987 Apr; 155(4):823-5. PubMed ID: 3102636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.